p.mwangi
TL2 Moderator · Seville
Contributes reviews on supplier material. Based in Seville.
Joined 6 August 2025 · last posted 7d
83Posts here
1Topics
1Solutions
1.8kLikes received
1.5kLikes given
22Badges
262Days visited
4.7kPosts read
Most-liked posts
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #58 · Compounds › Semaglutide · 22 Dec 2024 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading an MS report that only gives you a single number Replied, post #74 · Analytics › Mass spectrometry · 9 May 2025 · 30 likes post #73 is right about the mechanism and I think understates the practical bit. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Publishing an inconvenient result: a case study — the long version Replied, post #32 · Sourcing › Independent verification · 9 Nov 2025 · 29 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
New subcategory: rationale and scope Replied, post #83 · Meta › Announcements · 21 Oct 2025 · 29 likes post #82 answers the question as asked. The question underneath it is different. Archives: older announcements are archived by date. Checking archives is useful if you…
-
Retatrutide mass and identity: what a report should show Replied, post #13 · Compounds › Retatrutide · 9 Jul 2026 · 28 likes On post #9 — agreed on the reasoning, with one qualification. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #12 · Evidence › Journal club · 17 Apr 2025 · 26 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Read the Guidelines | bronze | 9 Aug 2025 |
| Basic User | bronze | 10 Aug 2025 |
| First Reply | bronze | 14 Aug 2025 |
| Asked Well | bronze | 14 Aug 2025 |
| First Topic | bronze | 17 Aug 2025 |
| Welcome | bronze | 21 Aug 2025 |
| First Link | bronze | 31 Aug 2025 |
| Generous | bronze | 2 Sep 2025 |
| First Quote | bronze | 3 Sep 2025 |
| First Tag | bronze | 8 Sep 2025 |
| First Solution | bronze | 26 Sep 2025 |
| Member | bronze | 5 Oct 2025 |
| Sourced | bronze | 9 Oct 2025 |
| Editor | bronze | 23 Oct 2025 |
| Reader | bronze | 15 Nov 2025 |
| Good Post | silver | 5 Dec 2025 |
| Consistently Generous | silver | 22 Dec 2025 |
| Nice Post | bronze | 18 Jan 2026 |
| Thank You | silver | 21 Mar 2026 |
| First Vendor Report | bronze | 14 Apr 2026 |
| Gives Back | gold | 30 Apr 2026 |
| De-escalator | gold | 13 Jun 2026 |